Sarah Fishman, M.D., a professor of medicine, endocrinology, diabetes, and bone disease at Icahn School of Medicine at Mount Sinai in New York City
As a monogenic disease, ATTR amyloidosis represents an ideal target for in vivo gene editing mediated by CRISPR-Cas9
Begin your journey Start treatment and get personalized coaching, ongoing support, and progress tracking through JourneyMeds
Interestingly, when the degradation of the inactive form of PC-PLC was inhibited, no mature PC-PLC was detectable in the cytosol (Rock et al., 1994
Recent studies show that exposure to GLP1-RA in the first trimester is not associated with a risk of major birth defects when compared with diabetes or obesity